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Posterior polymorphous corneal dystrophy (PPCD, also known as PPMD) is a rare disease involving metaplasia
and overgrowth of corneal endothelial cells. In patients with PPCD, these cells manifest in an epithelial morphology
and gene expression pattern, produce an aberrant basement membrane, and, sometimes, spread over the iris and
nearby structures in a way that increases the risk for glaucoma. We previously mapped PPCD to a region (PPCD3)
on chromosome 10 containing the gene that encodes the two-handed zinc-ﬁnger homeodomain transcription factor
TCF8. Here, we report a heterozygous frameshift mutation in TCF8 that segregates with PPCD in the family used
to map PPCD3 and four different heterozygous nonsense and frameshift mutations in TCF8 in four other PPCD
probands. Family reports of inguinal hernia, hydrocele, and possible bone anomalies in affected individuals suggest
that individuals with TCF8 mutations should be examined for nonocular anomalies. We detect transcripts of all
three identiﬁed PPCD genes (VSX1, COL8A2, and TCF8) in the cornea. We show presence of a complex (core
plus secondary) binding site for TCF8 in the promoter of Alport syndrome gene COL4A3, which encodes collagen
type IV a3, and we present immunohistochemical evidence of ectopic expression of COL4A3 in corneal endothelium
of the proband of the original PPCD3 family. Identiﬁcation of TCF8 as the PPCD3 gene provides a valuable tool
for the study of critical gene regulation events in PPCD pathology and suggests a possible role for TCF8 mutations
in altered structure and function of cells lining body cavities other than the anterior chamber of the eye. Thus, this
study has identiﬁed TCF8 as the gene responsible for approximately half of the cases of PPCD, has implicated
TCF8 mutations in developmental abnormalities outside the eye, and has presented the TCF8 regulatory target,
COL4A3, as a key, shared molecular component of two different diseases, PPCD and Alport syndrome.
Introduction
The cornea, positioned at the interface between the out-
side world and the internal structures of the eye, protects
the eye from environmental insult while maintaining
near-perfect transparency, so that light is able to pass
undistorted to the lens (Spencer 1996). From the outer
to the inner surface, the cornea consists of three main
layers: an outer stratiﬁed epithelium, a thickmiddle layer
of highly ordered collagenous structures and sparse cel-
lularity called the “corneal stroma,” and an inner single
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layer of endothelial cells that produce an unconventional
basement membrane called “Descemet membrane” and
that maintain the hydration and homeostasis of the cor-
neal stroma (Spencer 1996).
Posterior polymorphous corneal dystrophy (PPCD,
also known as PPMD [MIM #122000]) is a rare corneal
dystrophy that is often inherited in an autosomal dom-
inant manner (Pearce et al. 1969; Heon et al. 1995;
Moroi et al. 2003). Symptoms can range from very ag-
gressive to asymptomatic and nonprogressive, even
within the same family (Weisenthal and Streeten 1997).
The age at diagnosis is, most often, in the 2nd or 3rd
decade of life. PPCD usually affects both eyes.
Cellular abnormalities in PPCD include an altered
corneal endothelial cell structure, an unusual prolifer-
ation of endothelial cells, an aberrant structure of the
Descemet membrane, and a disturbed regulation of the
protein expression pattern (Weisenthal and Streeten
1997). Metaplastic changes in the cells of the endothe-
Krafchak et al.: TCF8 Mutations Cause PPCD 695
lium to cells with characteristics of epithelial cells in-
clude multilaminar growth (Boruchoff 1971; Rodrigues
et al. 1980) and the expression of a set of cytokeratins
that are not normally seen in the corneal endothelium
but are typical of epithelial cells (Boruchoff 1971; Ro-
drigues et al. 1980). In addition to the cellular abnor-
malities, the posterior two-thirds of the corneal endo-
thelial cell basement membrane, the Descemet mem-
brane, is abnormal (Weisenthal and Streeten 1997).
Several genes have been implicated in PPCD through
mapping studies and mutational analysis. PPCD1 was
mapped to a 30-cM locus on 20q11 with the use of
data from a ﬁve-generation family (Heon et al. 1995).
Subsequent work on this locus revealed mutations
thought to cause PPCD in the gene encoding the hom-
eodomain transcription factor VSX1 (GenBank acces-
sion number NM_199425), although no VSX1 muta-
tion was found in the family used for the initial mapping
of the PPCD1 locus (Heon et al. 2002). Screening for
mutations in the gene encoding collagen type VIII a2
(COL8A2 [GenBank accession number NM_005202]),
a gene implicated in the much more prevalent Fuchs
endothelial corneal dystrophy (FECD [MIM#136800]),
revealed mutations in two related individuals with
PPCD (Biswas et al. 2001).
In addition to these PPCD genes, two loci have been
mapped for another related disease, congenital heredi-
tary endothelial dystrophy (CHED [MIM #121700]),
one on each arm of chromosome 20 (Toma et al. 1995;
Hand et al. 1999). Additional insights into PPCD may
be gained from observing that mutations in genes en-
coding several type IV collagens, COL4A3 (Lemmink
et al. 1994) [MIM #120070], COL4A4 (Mochizuki et
al. 1994) [MIM #120131], and COL4A5 (Barker et al.
1990) [MIM #303630], occur in individuals with Al-
port syndrome, which is characterized by hereditary ne-
phritis and sensorineural hearing loss and can include
PPCD (Alport 1927; Colville and Savige 1997).
We have previously evaluated the role of each of these
genes and loci in PPCD in a large multigeneration family
(UM:139). Using linkage analysis, we excluded all of
the above genes from involvement in PPCD in this
family (Moroi et al. 2003). Subsequent linkage analysis
led to our recent report (Shimizu et al. 2004) that
PPCD in family UM:139 is linked to a new PPCD locus,
PPCD3, on 10p11.
One of 130 genes within the PPCD3 genetic inclusion
interval is the gene that encodes the two-handed zinc-
ﬁnger homeodomain transcription factor 8,TCF8 (Gen-
Bank accession number NM_030751, also known as
AREB6, BZP, Nil-2a, ZEB1, ZFHEP, Zfxh1A, and
dEF-1), which was originally reported as a repressor of
Il-2 gene expression (Williams et al. 1991). TCF8 plays
a critical role in embryonic development, since homo-
zygous null mice exhibit many skeletal defects and do
not survive beyond birth, whereas heterozygous null
mutant mice exhibit less severe skeletal and T-cell ab-
normalities (Higashi et al. 1997; Takagi et al. 1998).
There are no reports of ocular manifestations in either
homozygous or heterozygous Tcf8-null mice, but these
studies did not indicate that eyes were examined.
The unusual structure of TCF8, with its homeodo-
main region ﬂanked on either side by zinc ﬁngers, leads
to a diverse set of activities. It has been shown that each
zinc ﬁnger has slightly different DNA binding speciﬁc-
ities, each possibly having a different effect on gene
expression (Ikeda and Kawakami 1995). Of particular
interest, with regard to evaluation of TCF8 as a can-
didate PPCD gene, are the previous reports that TCF8
plays a role in the regulation of type I collagen expres-
sion (Terraz et al. 2001) and in the repression of the
epithelial phenotype (Frisch 1994; Grooteclaes and
Frisch 2000).
In the present study, we showTCF8mutations in both
familial and isolate cases of PPCD. We present evidence
of ectopic COL4A3 expression in the corneal endothe-
lium of the proband of the original PPCD3 family, and
we discuss the possibility that PPCD may include non-
ocular phenotypic features.
Material and Methods
Subjects
Study participants provided informed consent and
blood samples in accordance with a protocol approved
by the Institutional Review Board for Human Subject
Research of the University of Michigan Medical School.
Complete ophthalmologic examinationswere performed
as described elsewhere (Moroi et al. 2003), and partic-
ipants were classiﬁed as affected with PPCD if they
showed any of the following clinical features in at least
one eye: posterior vesicles or vesicular, geographic, or
band-like lesions at the level of the Descemet membrane
(Cibis et al. 1977; Miller 1997). Physicians performing
ophthalmologic exams and assigning affection status did
not know the subjects’ genotypes. None of the 11 pro-
bands in this study reported having hearing problems
or kidney disease that could indicate Alport syndrome.
Controls are race matched to cases (all white). The ages
of these controls ranged from 24 to 96, with an average
age of 63.
Molecular Genetic Analysis
Genomic DNA preparation, genotyping, clinical data
management, quality control, and data formatting for
markers D10S1243, D10S1781, D10S1654, D10S675,
andD10S1208 (Invitrogen) were performed as described
elsewhere (Shimizu et al. 2004) to conﬁrm haplotyping
in the vicinity of TCF8 in family UM:139. Using the
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Table 1
Sequences of Primers Used to Amplify and Sequence
TCF8 and VSX1
This table is available in its entirety in the online
edition of The American Journal of Human Genetics.
same methods, we also genotyped one marker per au-
tosome to conﬁrm the relationships in UM:A01 andUM:
797 and to conﬁrm that their mutations were de novo
(data not shown).
Sequencing Analysis of TCF8, VSX1 and COL8A2
PCR ampliﬁcation and sequencing ofTCF8 andVSX1
were performed with the primers listed in table 1.
COL8A2 was ampliﬁed and sequenced with primers de-
scribed elsewhere (Biswas et al. 2001). PCR ampliﬁca-
tion was performed with AmpliTaq Gold (Applied Bio-
systems), with 2.5 mM MgCl2, 2.0 mM dinucleotide
triphosphate, and 0.5 mM primers in a 25 mL reaction
volume. PCRs were cleaned with the Qiagen PCR pu-
riﬁcation kit (Qiagen). Sequencing was performed at the
University of Michigan Medical School Biomedical Se-
quencing Core facility with ABI Big Dye Terminator (Ap-
plied Biosystems) and read on either an ABI 3700 or
3730. Sequence traces were screened for mutations, both
manually and through the use of PolyPhred (Nickerson
et al. 1997), in conjunction with Phred/Phrap/Consed
(Ewing and Green 1998; Gordon et al. 1998). Refer-
ence sequence used was NM_030751 (UCSC Genome
Browser).
Strand-Speciﬁc Sequencing
To conﬁrm deletion and insertion mutations observed
as mixed sequence, the two alleles were cloned so they
could be sequenced separately. Fragments containing in-
sertion or deletion mutations were ampliﬁed as described
above and subcloned with the pGEM T-Easy Vector Sys-
tem (Promega), according to the manufacturer’s instruc-
tions. Cloned DNA was isolated with the Mini-Prep Kit
(Qiagen), followed by bidirectional sequencing accord-
ing to the method described above, with T7 and SP6
sequencing primers.
Mouse RNA Isolation and cDNA Synthesis
Tissues from 180-d-old C57BL/6 mice were stored in
TRIzol (Invitrogen) immediately after harvesting. RNA
was isolated by the TRIzol method in accordance with
the manufacturer’s protocol. Total RNA was puriﬁed
with an RNeasy Mini Kit (Qiagen). First-strand cDNA
synthesis was performed with a SuperScript First-Strand
Synthesis System for RT-PCR (Invitrogen).
Quantitation of RNA Levels
Real-time semiquantitative PCR (sqPCR) was per-
formed according to the manufacturer’s protocol, with
the iQ SYBR Green Supermix (BioRad) with 250 nM
primers for mouse: Tcf8, forward–5′-TGTCTTAGCTC-
CTCTCTTG-3′ and reverse–5′-ACTGCCCAGTTACC-
CACAAT-3′; Vsx1, forward–5′-ACTGCCCAGTTACC-
CACAAT-3′ and reverse–5′-AAGTGGCGTAAGCGA-
GAGAA-3′; COL8A2, forward–5′-GGTAAAGTATGT-
GCAGCCCA-3′ and reverse–5′-AGTAATACCTGAGG-
GACCAG-3′; and RpL19, forward–5′-GGGAAGAGG-
AAGGGTACTGC-3′ and reverse–5′-GGACGCTTCAT-
TTCTTGGTC-3′ on an iCycler (BioRad), under stan-
dard PCR conditions, with an annealing temperature of
59C. All sqPCR primer pairs were designed so that the
primers were located in different exons, resulting in an
intron-spanning ampliﬁcation event that could distin-
guish ampliﬁcation of reverse-transcribed RNA from
ampliﬁcation of genomic DNA. Data were analyzed as
described elsewhere, withRpL19 as a housekeeping con-
trol (Mandal et al. 2004).
Immunohistochemistry
Formalin-ﬁxed, 5-mm parafﬁn sections were rehy-
drated to buffer and were treated with Proteinase K
for 5 min. After peroxidase blocking, the sections were
incubated with serum, to block nonspeciﬁc binding, and
then with monoclonal antibodies MAB-1, MAB-3, and
MAB-5 (Wieslab), each at a concentration of 1:100, at
room temperature for 30 min. With use of the DAKO
AutoStainer and LSAB Kit (DAKO Cytomation), the
sections were then exposed to biotinylated secondary
antibody, developed with chromagen for 5 min, and
counterstained with hematoxylin.
Bioinformatics
Human sequences were annotated with the protein
translation and primer sequences with use of the Se-
quence Manipulation Suite. The sequence upstream of
the basement membrane collagen genes and the short-
chain collagen gene COL8A2 were searched for the
TCF8 core binding site ([T/G][T/G]CACCT[T/G]T) and
for proximal downstream secondary TCF8 binding sites
(GTTT[C/G]) 100 bp after the core site (Ikeda and Ka-
wakami 1995). This sequence pattern search was per-
formed with use of the fuzznuc module in the EMBOSS
package (Rice et al. 2000). Binding site simulations used
the Shufﬂe Utility, developed by Edward H. Trager at
the University of Michigan Department of Ophthal-
mology and Visual Sciences. Shufﬂe was used to gen-
erate 210,000 randomizations of the 20 kb upstream of
the start codon of COL4A1, COL4A2, COL4A3,
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Table 2
SNPs Found in Intronic Regions of TCF8
INTRONIC
SNP
PROBANDS CONTROLS
P
VALUE
No. of
Reference
Alleles
No. of
Variant
Alleles
No. of
Reference
Alleles
No. of
Variant
Alleles
c.48467ArG 19 3 219 55 0.39
c.68515GrA 3 19 13 261 0.06
COL4A4, COL4A5, COL4A6, and COL8A2. These
randomizations were performed by picking bases at ran-
dom from the native promoter sequence to ﬁll out the
randomized sequence one base at a time, thus retaining
the precise sequence composition of the native promoter
sequences while scrambling the order. The simulations
were completed with the use of fuzznuc to search for
the speciﬁc binding-site sequences within the random-
ized sequences.
Statistical Analysis
The signiﬁcance of the binding-site simulations was
evaluated by empirical P values, which were calculated
by taking the number of simulations showing binding
sites across all seven promoters equal to or greater than
the number found in the native promoters and dividing
that number by 210,000.
The independence of a particular SNP allele or ge-
notype and the PPCD phenotype was assessed with the
use of a x2 test for independence, with P values corre-
sponding to x2 with 1 df comparing allele frequency by
disease status (table 2). A model-based x2 test for in-
dependence of SNP alleles and the PPCD phenotype was
performed by comparing the number of affected indi-
viduals with and without the major allele with those in
the control sample. One of the two intronic SNPs,
c.685ArG, is in dbSNP (accession number rs220060).
Results
TCF8 Frameshift Mutation in the Original PPCD3
Family
Screening for mutations in TCF8 in the proband of
family UM:139 revealed the presence of a 2-bp deletion,
2916_2917delTG (ﬁg. 1a), in the last exon of the gene.
This frameshift mutation alters the amino acids down-
stream of the deletion and maintains an open reading
frame for 13 codons before the premature termination
signal, which, if a protein is produced, would cause the
elimination of most of the last zinc-ﬁnger cluster and
the acidic activation domain (ﬁg. 2). Follow-up screening
of other members of UM:139 showed that the mutation
is present in every one of the 13 affected family members
who were screened (ﬁg. 1b).
If we consider unaffected family members, we ﬁnd that
penetrance is apparently incomplete. Individual III-1,
who has the mutation but does not have PPCD, repre-
sents apparent nonpenetrance, since both PPCD and the
mutation are present in her child (IV-1) and two grand-
children (V-1 and V-2); however, we cannot rule out the
possibility that she will still develop the trait at a later
age. Individual IV-18, who was 27 years old at the time
of examination and carries the affected haplotype and
the deletion but is apparently not affected with PPCD,
may represent a case of age-related penetrance, because
some affected family members showed onset at a later
age.
Data for individual III-15 and her siblings suggest pos-
sible germline mosaicism in their father, individual II-9.
On the basis of haplotyping performed in coordination
with the mapping of the locus, III-15 and her daughter
IV-28 originally appeared to be cases of nonpenetrance,
because they both carried the entire affected haplotype
but were not affected with disease (Shimizu et al. 2004).
However, III-15 and IV-28 both possess the affected hap-
lotype without possessing the TCF8 mutation present in
their affected relatives. Fine mapping of this region in
this family conﬁrms the transmission of the entire af-
fected haplotype from II-9 to III-15 and then to IV-28
(ﬁg. 1), so a double recombination event would have to
be conﬁned to a region of ∼1.8 million bases to explain
the presence of the normal allele on the affected hap-
lotype. Back mutation in III-15 seems highly unlikely,
since it would require reinserting two bases at exactly
the correct position in the gene. Germline mosaicism
seems a more probable explanation for the fact that II-
9 apparently transmitted three distinct versions of this
section of chromosome 10 to his children: the affected
haplotype with the deletion, the affected haplotype with-
out the deletion, and the normal haplotype without the
deletion. However, additional information on genotypes
from generation II, especially siblings of II-9, would be
needed to take this beyond the realm of speculation.
TCF8 Mutations in Additional Families
Screening for TCF8 mutations in samples from the
probands of 10 other unrelated PPCD families revealed
that 4 of these 10 probands carry mutations that ter-
minate or shift the reading frame (ﬁg. 3). Three of the
mutations (c.1332_1335delCAAT, c.1350CrT, and
c1578_1579insG) would, if truncated protein were pro-
duced, eliminate the homeodomain, the second cluster
of zinc ﬁngers, and the acidic activation domain (ﬁg. 2).
The c.2184GrT mutation would result in the elim-
ination of the second cluster of zinc ﬁngers and the
acidic activation domain (ﬁg. 2). The c.2184GrT and
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Figure 1 Haplotype and mutational analysis of the TCF8 2916_2917delTG mutation in family UM:139. a, Based on sequencing of cloned
versions of the two alleles present in UM:139, the frameshift mutation (M) sequence trace is shown on the left, and the corresponding reference
(R) sequence, NM_030751, is shown on the right. b, Haplotyping over the 8.55-cM PPCD3 region, with the 2916_2917delTG mutation
designated M and the reference allele designated R. All relationships of genotyped individuals are correct as depicted, as determined from the
previously reported UM:139 genome scans (Moroi et al. 2003; Shimizu et al. 2004). A large number of nonparticipating descendants of members
of generation II do not appear in this ﬁgure. Open symbols indicate absence of PPCD, ﬁlled symbols indicate affected individuals, ﬂags indicate
individuals with hernia, and crossed symbols indicate individuals considered to have indeterminate phenotypes, since they do not have PPCD
but do have other corneal ﬁndings, such as guttae or FECD. c, Traits that did not cosegregate with the mutation include late-onset hearing
loss, migraine headaches, lupus, and arthritis. The locus map shows the order of markers and intermarker distances. The germline of II-8
contains three distinct versions of chromosome 10 shown among his progeny: unaffected haplotype without deletion (III-3 and III-17), affected
haplotype plus deletion (III-1, III-5, III-7, III-10, III-11, and III-12), and affected haplotype without deletion (III-15 and IV-28). The three possible
explanations include back mutation, a double recombination event, and germline mosaicism in individual II-9.
c.1578_1579insG mutations segregate with disease in
these families, but the data are not statistically signiﬁcant
because of small family size (ﬁg. 3a and 3c). The other
two mutations (c.1350CrT and c.1332_1335delCAAT)
are found in the only affected member of their families
and are likely examples of de novo mutations (ﬁg. 3b
and 3d). To verify parentage in these two trios in the
presence of the apparent de novo mutations, one mi-
crosatellite marker on each autosome was genotyped,
and each trio was found to show inheritance consistent
with the expected Mendelian pattern (data not shown).
There were no nonsense or frameshift mutations
among 128 race-matched (white) normal controls. One
69-year-old normal control had a novel in-frame dele-
tion (c.3193_3198delGAGGAG) that was not seen in
the PPCD cases. This deletion removes two residues in
a repeat of seven glutamic acid residues (E1065_
E1066delEE). Whereas the presence of a glutamic acid
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Figure 2 Structure of the TCF8 transcript. Locations of the mutations and the sequence variant relative to exons encoding functional
domains are shown. TCF8 encodes a homeodomain (HD) ﬂanked by two zinc-ﬁnger clusters (Z1–Z4 and Z5–Z7). An acidic activation domain
(AAD) is encoded after the last zinc-ﬁnger domain.
repeat at this location is well conserved across species,
the speciﬁc length of the repeat is not conserved (data
not shown). Although it is possible that this normal con-
trol individual could develop PPCD after the age of 69,
these data suggest that this particular deletion is benign.
In addition to the protein-altering changes described
above, SNPs were found in PPCD cases and normal con-
trols. One of these SNPs was found 67 bases down-
stream of the end of exon 4 (c.48467ArG), and the
other was found 15 bases upstream of the start of exon
6 (c.68515GrA). Neither of these SNPs provides
strong evidence of differential distribution among cases
compared to controls when comparing the frequency of
alleles, genotypes, or the common allele among affected
individuals (table 2).
The Role of Other PPCD Genes in These Families
We resequenced all known exons and adjacent splice
sites of the previously reported PPCD genesVSX1 (Heon
et al. 2002) and COL8A2 (Biswas et al. 2001) in DNA
samples from our probands. We found one novel silent
change (R166R, c.496CrG) in VSX1 that is located at
the same position as a previously reported VSX1 SNP
but involves a different substitution (Heon et al. 2002).
This change creates an AG, but neither NetGene nor
NNSPLICE splice recognition software (Brunak et al.
1991; Hebsgaard et al. 1996; Reese et al. 1997) rec-
ognizes this as a potentially new acceptor splice site,
although both programs do recognize the actual accep-
tor splice site for that exon. No protein-altering base
changes were found in either gene, indicating that mu-
tations in these genes are unlikely to be the cause of
PPCD in our subjects.
Nonocular Phenotypic Features
By family report we ﬁnd that, among the 14 males
with TCF8 mutations, inguinal hernia and/or hydrocele
is reported to be present in 11 individuals with PPCD,
absent from 1, and uninformative in 2 for whom we
lack information regarding hernias or hydroceles (UM:
513) (ﬁg. 1 and ﬁg. 2). Among the females with TCF8
mutations, we found one with umbilical hernia subse-
quent to Cesarean section delivery, one with failure to
form a vaginal opening, seven with no report of hernia,
and one for whom the information is not available. It
is unclear whether any of these traits in women are re-
lated to the TCF8 mutation. Some additional reports of
hernia among uncharacterized branches of several fam-
ilies raise questions about how simple or complex the
situation will appear by the time everyone is fully char-
acterized for both ocular and nonocular characteristics.
We ﬁnd evidence of orthopedic anomalies among af-
fected individuals in the four TCF8 mutation families
for whom information was available. The proband of
UM:139, the main person for whom any details are
available, reported extra vertebrae in her lower back,
bone spurs on vertebrae, and lumps on her kneecaps.
Bony lumps on the palms and soles of the feet, associated
with Dupuytren’s contractures, are reported for four af-
fected members of UM:139, and the orthopedic trait,
Osgood-Schlatter disease, was reported among one af-
fected individual in each of UM:139 and UM:797. Otos-
clerosis was observed in one member of UM:139, but
other cases of late-onset hearing loss that do not coseg-
regate with PPCD may be unrelated. Other indications
of possible orthopedic anomalies include reports of
kneecap dislocations and bone spurs which, in some
cases, were severe enough to warrant surgery, but ra-
diographs were not available to conﬁrm any of theminor
bone anomalies seen in the mice heterozygous for the
Tcf8 knockout mutation (Takagi et al. 1998). Evaluation
of medical records or examination will be required to
allow us to draw ﬁrm conclusions about bone anomalies
in PPCD.
A review of the records for family UM:139 indicates
the presence of ocular phenotypes besides PPCD. We
have previously reported the presence of guttae in several
individuals in the family (Shimizu et al. 2004), but guttae
do not cosegregate with PPCD or TCF8 mutations. A
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Figure 3 Additional PPCD families with TCF8 mutations. The genotype of each individual at the relevant locus is displayed. M indicates
the mutant allele and R indicates the reference allele. In each case, the mutant sequence trace is on the left and the sequence trace corresponding
to the reference allele is on the right. a and b, Families with nonsense mutations. c and d, Families with frameshift mutations. Symbols are as
described in ﬁgure 1. Relatives in UM:A01 are shown as having indeterminate ocular phenotype because we have not examined them and have
no records on them, but since the proband’s father has been conﬁrmed and has neither PPCD nor the TCF8 mutation, we do not expect to
ﬁnd PPCD or the TCF8 mutation in that branch of the family. Relationships are conﬁrmed as depicted for all genotyped individuals.
review of records also revealed that one member (III-3)
of the family has been diagnosed with the more common
corneal dystrophy, Fuchs endothelial corneal dystrophy
(FECD), and the proband reports that two others have
been diagnosed with FECD (III-11 and III-112), but we
do not have recent-enough records to conﬁrm this. Nei-
ther guttae nor FECD appear to cosegregate with PPCD
or TCF8 mutations.
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Evaluation of Expression of PPCD Genes In Ocular
and Nonocular Tissues
Real-time semiquantitative PCR (sqPCR) on mouse
tissue conﬁrms the expression of all three known PPCD
genes, Tcf8 (GenBank accession number NM_011546),
Vsx1 (GenBank accession number NM_054068), and
Col8a2 (GenBank accession number NM_199473), in
the eye and, more speciﬁcally, in the cornea (ﬁg. 4). Tcf8
and Vsx1 are expressed at rather high levels in the retina,
showing mRNA levels at 450% and 178%, respectively,
that of the housekeeping control, ribosomal subunit
gene Rpl19 (GenBank accession number NM_009078).
Col8a2 shows more modest expression in all tissues,
including the retina, with expression levels at ∼4% that
of Rpl19. All three genes show low-level expression in
the cornea, with Tcf8 and Vsx1 showing similar levels
of expression at 17% and 14%, respectively, of Rpl19
expression, whereas Col8a2 shows lower levels of ex-
pression at ∼6% of Rpl19 expression. Elsewhere in the
body, Vsx1 shows very low expression levels in the brain
(0.03%) and absent expression in the lung, liver, and
spleen. Col8a2 shows very low levels of expression in
all of the nonocular tissues screened, with the highest
level seen in the heart at 0.2% of Rpl19 expression.Tcf8
shows low-level expression in these organs, with 3% and
5% of Rpl19 expression in the brain and heart, respec-
tively, and 11.5% in the other organs.
In Silico Binding Site Search
On the basis of evidence from previous studies that
(1) collagen abnormalities occur in the Descemet mem-
brane in PPCD (Terraz et al. 2001), (2) COL8A2 is
implicated in both FECD and PPCD (Colville and Savige
1997), and (3) defects in a-type 4 collagen genes are
involved in Alport syndrome (Colville and Savige 1997),
we did a preliminary evaluation of the potential for
TCF8 regulation of expression of these genes by search-
ing the promoter regions of basement membrane col-
lagens COL4A1, COL4A2, COL4A3, COL4A5, and
COL4A6, and the short-chain collagen, COL8A2, for
possible TCF8 binding sites (Ikeda and Kawakami 1995)
(table 3). A search of the 20 kb upstream of the tran-
scription start shows 12 possible TCF8 core binding sites
([T/G][T/G]CACCT[T/G]T) (Ikeda and Kawakami
1995) across all 7 of these genes, with 3 sites in
COL4A2, 2 each inCOL4A3, COL4A5, COL4A1, and
COL8A2, 1 in COL4A6, and none in COL4A4. Sta-
tistical analysis of 210,000 in silico simulations, involv-
ing searches for this core sequence after scrambling the
promoter sequences, indicates that the probability of ob-
serving these data across all seven genes by chance for
the core sequence alone was unlikely ( ). How-Pp .0001
ever, functional studies would be needed to evaluate the
biological signiﬁcance of these observations.
A secondary sequence (GTTT[C/G]) increases the
strength of TCF8 binding when it is found close to the
core sequence (Ikeda and Kawakami 1995). A corre-
sponding search of these promoter regions shows that
only the COL4A3 promoter contains a complex site
consisting of the core and proximal (within 100 bases)
downstream secondary sequence.
Immunohistochemical Examination of Type IV Collagen
Expression
On the basis of the observation that the promoter of
COL4A3, one of the Alport syndrome collagen genes,
has both a core and a secondary binding site, whereas
the other genes tested do not, we evaluated COL4A3
and two related collagens (COL4A1 and COL4A5) for
altered expression in corneal endothelium in the presence
of a TCF8 mutation. We evaluated the expression of
these proteins in the cornea of the proband of family
UM:139 and in a control cornea from an individual
without PPCD. In ﬁgure 5, we show that COL4A1 and
COL4A5, the promoters of which lack a secondary
binding site, are not expressed in either the PPCD or
control cornea. In contrast, COL4A3 is expressed in the
corneal endothelium of the UM:139 proband, but not
in that of the control eye.
Discussion
Mutations in TCF8 Cause PPCD
Our data suggest that a large proportion of PPCD is
caused by mutations in the gene encoding the two-
handed zinc-ﬁnger homeodomain transcription factor
TCF8. Although the sample size is too small to allow a
precise determination of TCF8 mutation frequency, 5 of
11 probands (45%) in this study were found to have
PPCD attributable to TCF8mutations. None of our pro-
bands had mutations in PPCD genes VSX1 or COL8A2,
but, in previous studies, mutations in VSX1 and
COL8A2 account for smaller proportions of the PPCD
population (9% and 7%, respectively) (Biswas et al.
2001; Heon et al. 2002). Thus, the causative mutation
remains to be accounted for in a sizable fraction of the
PPCD population, which suggests that there might be at
least one additional PPCD gene remaining to be found.
Both skipped generations and unaffected status among
younger mutation carriers must be kept in mind when
dealing with PPCD. Penetrance is high but incomplete
in families in which PPCD results from TCF8 mutation,
and age-related penetrance may be an issue. In three
families with TCF8 mutations in which additional af-
fected relatives were available to be tested (UM:139,
UM:461, and UM:513), all affected family members
each have one copy of the TCF8 mutation found in the
probands of those families. However, in the one large
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Figure 4 Quantitation of transcript levels. Real-time sqPCR on cDNA from various mouse tissues used primers for mouse genes Tcf8
(NM_011546), Vsx1 (NM_054068), and Col8a2 (NM_199473). Eye posterior includes retinal pigment epithelium, choroid, and sclera.
family studied (UM:139), we found a case of nonpe-
netrance (III-1) and another individual whose unaffected
status may be the result of age-related penetrance (IV-
18).
Two cases, previously reported elsewhere, of apparent
nonpenetrance (III-15 and IV-28), on the basis of initial
haplotyping in family UM:139 (Shimizu et al. 2004),
turn out to lack the deletion mutation present in their
affected relatives. Although alternative scenarios, such
as local recombination and back mutation, were con-
sidered, the most likely explanation seems to be germline
mosaicism in individual II-9. This individual appears to
have passed three different copies of chromosome 10 to
his children: one with the affected haplotype and the
deletion, one with the affected haplotype and no dele-
tion, and one with the unaffected haplotype and no de-
letion. Similar situations have been reported in the lit-
erature. A recent Alzheimer disease study presents a
situation in which siblings received the identical hap-
lotype from an affected parent, but only one inherited
the causative mutation (Beck et al. 2004). Similar situ-
ations have also been reported in VATER association
(Reardon 2001), von Hippel-Lindau disease (Sgambati
et al. 2000), X-linked a-thalassaemia mental retardation
syndrome (Bachoo and Gibbons 1999), and hemophilia
B (Cutler et al. 2004).
De Novo Mutations
Some of the TCF8 mutations observed in this study
are de novo mutations. If we are correct in our hypoth-
esis that II-9 in UM:139 was a germline mosaic, then
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Table 3
Putative TCF8 Binding Sites in Promoters of Basement Membrane
Collagens and COL8A2
Gene Symbol
and Core Site
Sequence
Bases from
ATG to
Core Site
Proximal
Downstream
Secondary Site
Sequence
Bases from
ATG to
Secondary Site
COL4A1:
GTTACCTGT 18,539 … …
TGCACCTGT 13,723 … …
COL4A2:
TGCACCTGT 11,753 … …
GTTACCTTT 10,184 … …
TGTACCTGT 7,394 … …
TTCACCTGT 910 … …
COL4A3:
GTCACCTGT 3,902 GTTC 3,835
TGCACCTGT 1,161 … …
COL4A5:
TGCACCTGT 11,721 … …
TGTACCTGT 6,743 … …
COL4A6:
GGCACCTGT 5,936 … …
COL8A2:
TTCACCTGT 9,119 … …
TGCACCTGT 3,481 … …
60% (3 of 5) of the mutations found in this study are
likely de novo mutations, including 25% (1 of 4 pro-
bands) of familial cases of PPCD, as well as 29% (2 of
7) of nonfamilial cases. The signiﬁcance of this unusual
level of de novo mutations remains unclear. We did not
ﬁnd a single TCF8 mutation shared by multiple families
that might indicate a hotspot for mutation, and ampli-
ﬁcation of a simple-sequence repeat is not involved. One
alternative basis for a high de novo mutation frequency
would be reduced reproductive ﬁtness of the mutant al-
lele(s), but PPCD does not cause the kind of death or
disability before reproductive age that is seen in some
other disorders withmany reports of germlinemosaicism
and de novomutation such as DMD (Bullock et al. 1996;
Mukherjee et al. 2003; Ferreiro et al. 2004). It is inter-
esting to note that, in the one family in which the mu-
tation has been transmitted to progeny across four gen-
erations, the deletion is the most C-terminal of the
mutations, which would leave most of the functional
domains intact if the gene product is, indeed, produced
(ﬁg. 2). It may be that the higher-than-expected de novo
mutation rate observed here is simply due to chance and
that screening a larger PPCD population for mutations
in TCF8 will yield a lower de novo mutation rate. This
issue is, however, worth further examination, given the
apparent co-occurrence of nonocular traits with TCF8
mutations.
Expression of the PPCD Genes
Our ﬁnding that all three PPCD genes, Tcf8, Vsx1,
and Col8a2, are expressed in the cornea suggests that
the endothelial to epithelial changes that characterize
PPCD may result from the direct consequences of mu-
tations in these genes in corneal endothelial cells, rather
than from indirect processes that originate elsewhere. In
the BodyMap database, TCF8 transcripts are reportedly
localized to the actual endothelial layer. Our data (ﬁg.
4), plus information from the UniGene Database, indi-
cate that TCF8 is expressed in a variety of organs, and
its role in repressing genes such as E-cadherin has been
reported in cancers originating from a number of dif-
ferent cell types (Navarro et al. 1993; Ohira et al. 2003).
Given the expression pattern of this gene, other nono-
cular tissues or organs may be susceptible to as-yet un-
identiﬁed effects of TCF8 protein truncation or
haploinsufﬁciency.
The PPCD3 Phenotype
The ocular ﬁndings of the PPCD3 phenotype, as ex-
empliﬁed by the subjects in UM:139, include corneal
vesicles and bands in the corneal endothelium, retro-
corneal membrane, and syneciae in the drainage angle
(Moroi et al. 2003; Shimizu et al. 2004). Although guttae
and FECD were also seen in family UM:139, neither
cosegregates with the TCF8 mutation or the PPCD phe-
notype. No unusual ocular features other than PPCD
were noted in UM:139 or the other families. The evi-
dence for dysfunction of the cornea affected by TCF8
mutations is also supported by histopathology presented
here and elsewhere (Moroi et al. 2003). Thus, the
PPCD3 ocular phenotype resulting fromTCF8mutation
appears to be a simple PPCD phenotype, although it
shows great variation in range of severity (Moroi et al.
2003).
Although most studies of PPCD have focused on the
eye, there is also reason to ask whether TCF8 mutations
might involve abnormalities in tissues such as the lining
of the abdominal cavity, since, when responding to in-
jury, cells lining body cavities can show a pattern of
metaplasia similar to that seen in the cornea in PPCD
(Waring 1974). Inguinal hernia is a relatively common
pediatric condition occurring in 10–20 per 1,000 live
births and ∼6 times more often in boys than in girls
(Tam 1990; Kapur et al. 1998), but our data suggest a
dramatically higher risk of the related conditions hernia
or hydrocele among males with TCF8 mutations. It is
estimated that as many as 20% of inguinal hernia pa-
tients have a positive family history (Tam 1990), point-
ing to a potential genetic etiology for this common con-
dition. Inguinal hernias are also associated with several
inherited connective tissue diseases like Ehlers-Danlos
syndrome (Carr et al. 1994) and primary joint hyper-
mobility syndrome, which also includes features of Mar-
fan syndrome, Elhers-Danlos syndrome, and osteoge-
nesis imperfecta (Skoumal et al. 2004). It has previously
been proposed elswhere that defects in the level of col-
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Figure 5 Immunohistochemical detection of type IV collagens in corneal endothelium. The corneal endothelium, as marked by vertical
arrows, is on the right in each panel. Positive intercytoplasmic staining for COL4A3 in the UM:139 proband’s corneal endothelial cells is
indicated by horizontal arrows in the sample from the proband COL4A3 panel. In the proband panels, there is a retrocorneal ﬁbrous membrane
interposed between the endothelium on the right and the well-deﬁned Descemet membrane on the left. This retrocorneal ﬁbrous membrane is
not present in the control panels. COL4A1 and COL4A5 signals are not seen in samples from either the proband or the control.
lagen synthesis, like those seen in PPCD, are involved
in the development of hernias (Bendavid 2004). The lo-
cation and congenital nature of most of the hernias/
hydroceles in these families points to a developmental
anomaly in which the inguinal ring remains open after
the ﬁnal migration of the sex organs, leading to an in-
guinal hernia (Tam 1990; Kapur et al. 1998).
Additional evidence for possible developmental effects
of TCF8 mutations comes from studies of a mouse Tcf8
knockout model (Takagi et al. 1998). The homozygous
animals with both copies of Tcf8 knocked out showed
profound abnormalities in bone development. The het-
erozygous animals that represent a more appropriate
model for PPCD showed minor bone abnormalities, in-
cluding fusion of the smallest ribs. The presence of a
variety of orthopedic anomalies among affected mem-
bers of three of the families include extra vertebrae, bone
spurs, otosclerosis, Osgood-Schlatter disease, and Du-
petreyn’s contractures, but clinical details and radio-
graphs will be needed to fully evaluate which orthopedic
anomalies are part of the phenotype.
Thus, our evidence suggests that PPCD should no
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longer be considered a strictly ocular trait. The co-oc-
currence of TCF8 mutation and hernia/hydrocele pro-
vides strong evidence of greatly increased risk of at least
one nonocular feature of PPCD. The evidence for or-
thopedic anomalies is less compelling because more in-
formation is needed. Given that TCF8 is expressed at
many locations in the body, there remains the possibility
that there are additional nonocular features to PPCD
that were not identiﬁed from the limited information
available by family report. Clearly, we need not only a
more detailed evaluation of nonocular developmental
and clinical features that can result from TCF8 muta-
tions but also to evaluate those same features in PPCD
in families lacking TCF8 mutations, so that we can de-
termine which are speciﬁc to TCF8 mutation cases and
which apply to PPCD in general.
Haploinsufﬁciency
Haploinsufﬁciency may play a role in the PPCD phe-
notype because all of the mutations we observed are
predicted to truncate the protein, a situation that has
sometimes been found to lead to nonsense-mediated de-
cay of the mutant message (McIntosh et al. 1993) (ﬁg.
3). Further studies will be needed to evaluate this hy-
pothesis. Alternatively, haploinsufﬁciency could result if
the protein is made but lacks activity. Indeed, haploin-
sufﬁciency is a well-established disease mechanism for
other homeodomain transcription factors, such as
LMX1B (Vollrath et al. 1998) and PAX6 (Martha et al.
1994). If haploinsufﬁciency is the mechanism by which
TCF8 mutations affect regulation of gene expression,
then the retina might be spared the effects of partial loss
of TCF8 function because the retinal level of the Tcf8
transcript is 110 times that observed in the cornea. Thus,
the levels of TCF8 may be sufﬁcient to maintain retinal
function, whereas this may not be the case in the cornea,
where expression levels are much lower.
Alternatively, if the protein is indeed made from the
mutant allele (ﬁg. 2), a truncated TCF8 protein might
lose some functions but not others, rather than simply
reducing overall TCF8 functional levels. Elimination of
some functional domains while leaving others has the
potential to result in novel regulatory activities, with the
possibility that dominant negative effects could be in-
volved. Because cell-speciﬁc variation in TCF8 functions
has been reported (Ikeda and Kawakami 1995; Costan-
tino et al. 2002), novel dominant negative effects could
affect the cornea, but not the retina, if the critical func-
tions are relevant to the cornea, but not to the retina.
Models
Before our study, models for PPCD needed only to
explain corneal endothelial metaplasia as well as the
abnormalities in Descemet membrane. Our study sug-
gests that such models now also need to account for
altered gene regulation and developmental events else-
where in the body. On the basis of genetic evidence from
the ﬁve families with TCF8 mutations reported here and
the molecular evidence from expression studies, we pro-
pose that TCF8 mutations produce the full PPCD phe-
notype through failure to correctly regulate multiple, dif-
ferent genes in more than one cell type in the body.
The ﬁndings reported here support our model, in
which aberrant regulation of basement membrane col-
lagen synthesis contributes to aberrant formation ofDes-
cemet membrane. We showed aberrant expression of
COL4A3 in the presence of a heterozygous TCF8 mu-
tation in the corneal endothelium of the proband of UM:
139, but not in the normal cornea, which is in keeping
with previous immunoelectron microscopy studies (Sa-
wada et al. 1984; Sawada et al. 1987). Mutations in
genes encoding the basement membrane collagens
COL4A3 and COL4A5 have previously been shown
elswhere to disrupt the structure of some basementmem-
branes, leading to PPCD associated with Alport syn-
drome (Colville and Savige 1997). Thus, we ﬁnd
COL4A3 as a shared molecular component of the pa-
thology of PPCD and Alport syndrome, which can in-
clude PPCD as one aspect of the phenotype.
Abnormal basement membrane formation may go be-
yond ectopic expression of COL4A3. We have previ-
ously shown that some cytokeratins that are usually ex-
pressed in the corneal epithelium are abnormally present
in the diseased corneal endothelium of the UM:139 pro-
band (Moroi et al. 2003), and TCF8 has been implicated
in repression of the epithelial cell adhesion genes E-cad-
herin, desmoglein, and plakoglobin (Grooteclaes and
Frisch 2000). In addition, although we do not see evi-
dence of expression of COL4A1 or COL4A5 in either
normal or PPCD cornea, we do not yet know whether
TCF8 mutations are affecting expression of the other
four basement membrane collagens or COL8A2, the
PPCD gene that we have shown is expressed in normal
cornea. However, it may not be necessary to invoke ad-
ditional regulatory changes, since simply altering the
basement membrane composition apparently can mod-
ify epithelial protein expression (Kurpakus et al. 1992).
Yet to be tested is our hypothesis that aberrant reg-
ulation of collagens elsewhere in the body will also turn
out to be contributing to the phenotype. Support for the
idea that collagen regulation might be contributing to
bone abnormalities in the mouse or human subjects
comes from previous reports of TCF8 repression of ex-
pression of type I collagen in mouse osteoblasts through
binding to sequences almost 20 kb away from the start
codon (Terraz et al. 2001). In addition, hernias have
previously been reported to be associated with aberrant
regulation of type I and type III collagens (Friedman et
al. 1993; Carr et al. 1994; Skoumal et al. 2004), an
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observation of great interest relative to the ﬁnding of
hernias in males with PPCD.
In summary, we have shown that mutations in TCF8
apparently cause ∼50% of PPCD. We have identiﬁed a
shared molecular component of disease etiology for
PPCD and Alport syndrome through identiﬁcation of
COL4A3 as a possible target of TCF8 regulation. And,
ﬁnally, we have identiﬁed nonocular features in individ-
uals with PPCD that suggest a need for a more detailed
evaluation of the full phenotype.
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